Omeros | OMER - 流动负债



金融业
股票价格
USD
资产
USD 200.57M
现金及等价物
USD 1.9M
销售成本
USD 33.16M
流动资产
USD 69.65M
流动负债
USD 85.5M
债务
USD 442.16M
股息收益率
0
EBIT
USD -48.15M
EBITDA
USD -47.96M
员工
196
EPS每股收益
USD -1.12
股本和储备
USD -228.69M
销售毛利
USD -33.16M
债务利息支出
USD 4.05M
贷款资金
USD 403.72M
市值
USD 1.05B
净收入
USD -32.23M
营业费用
USD 59.16M
营业利润
USD -35.41M
普通股股本
USD 611K
税前利润
USD -65.12M
销售收入
USD 0
销售和管理费用
USD 11.32M
股票
USD 712K
贸易债权人
USD 8.84M
应收帐款人
USD 8.08M


流动负债 更改 日
Adma Biologics USD 75.76M 2.22M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Immunic USD 38.36M 7.74M 2026-03
Insmed USD 438.74M 77.74M 2026-06
Knight Therapeutics CAD 165.26M 12.58M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Rockwell Medical USD 10.95M 259K 2025-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06